Mesothelin-Targeted Immunotherapy Pipeline Market Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage
24. Oktober 2024 10:15 ET
|
Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Mesothelin-Targeted Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic...
PSMA Targeted Therapy Pipeline Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage
24. Oktober 2024 10:01 ET
|
Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "PSMA - Targeted Therapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic information on...
Advanced Liver Cancer Therapeutics Research 2024: Comprehensive Insights About 50+ Companies and 50+ Pipeline Drugs - Product Type, Stage, Route of Administration, and Molecule Type
01. Juli 2024 07:54 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Advanced liver cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Advanced liver cancer -...
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market to Surge to US$ 11.28 Billion by 2034, Propelled by Tranformative Cancer Treatments
27. Mai 2024 09:43 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Chimeric Antigen Receptor (CAR) T-Cell Therapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report...
Chimeric Antigen Receptor Macrophage (CAR-M) Immunotherapy Drug Pipeline Research 2024
17. April 2024 09:56 ET
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "Chimeric Antigen Receptor Macrophage (CAR-M) Immunotherapy - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's...
Global Natural Killer Cells Therapeutics Research Report 2023: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2022 and 2023-2028
03. Januar 2024 11:33 ET
|
Research and Markets
Dublin, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The "Global Natural Killer Cells Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Global Claudin 18.2 Targeted Therapy Research Report 2023-2028: Milestone Approval - Zolbetuximab's FDA Approval Paves the Way as the First CLDN18.2-Targeted Drug
15. Dezember 2023 05:18 ET
|
Research and Markets
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The "Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's...
Immunotherapy Targeting Mesothelin: A Comprehensive 2023 Pipeline Review
14. Dezember 2023 05:43 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Mesothelin-Targeted Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. A groundbreaking review of...
Global CD19 Antibody Market Projected to Exceed $10 Billion by 2028, Driven by Promising Pipeline of Therapies
09. November 2023 05:58 ET
|
Research and Markets
Dublin, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The "Global CD19 Antibody Market & Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global CD19...
Global CD19 Antibody Market Set to Surpass $10 Billion by 2028: A Revolutionary Era in Immunotherapy
03. November 2023 07:43 ET
|
Research and Markets
Dublin, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The "Global CD19 Antibody Market and Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global CD19 Antibody...